• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Actinium Pharmaceuticals Inc (NY: ATNM )

    7.455 +0.085 (+1.15%)
    Streaming Delayed Price Updated: 9:38 AM EDT, Jun 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Actinium Pharmaceuticals Inc

    < Previous 1 2 Next >
    Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024
    These are the biotech stocks under $10 that are attractively valued and have potential catalysts in the form of positive clinical trials news 
    Via InvestorPlace
    Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
    These are the biotech stocks to buy for a meme rally as they represent companies with positive impending news related to clinical trials. 
    Via InvestorPlace
    3 Cheap Biotech Stocks to Buy Now: May 2024
    Many of these cheap biotech stocks are on their way to achieving FDA approval for their drugs to enter the market. 
    Via InvestorPlace
    Exposures Product Safety
    ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q1 2024
    ATNM stock results show that Actinium Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
    The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate. 
    Via Investor's Business Daily
    (ATNM) - Analyzing Actinium Pharmaceuticals's Short Interest
    Via Benzinga
    Actinium Shares Are Trading Higher After Positive Data From Acute Myeloid Leukemia Trial
    Via Benzinga
    With Upcoming Pivotal Data, Analyst Sees 145% Upside In Actinium
    Via Benzinga
    Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
    With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks. 
    Via InvestorPlace
    High-Risk, High-Reward: Little-Known Biotech Stock ATNM Could Soar on Breakthrough Cancer Treatment
    ATNM stock offers moonshot or crash-landing possibilities as Actinium Pharmaceuticals works relentlessly to advance life-changing treatments. 
    Via InvestorPlace
    7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
    Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Actinium Pharma – Pivotal Results From Key New Drug In The Fight Against Cancer
    Sandesh Seth, CEO & Chairman of the Board of Actinium Pharmaceuticals (NASDAQ: ATNM), was recently a guest on Benzinga’s All-Access. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
    Via Benzinga
    Actinium Pharma Cratered 37% Over Two Days — Here's Why, According To CEO Sandesh Seth
    Actinium CEO Sandesh Seth says the tumble this week had little to do with clinical data. 
    Via Investor's Business Daily
    Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
    Via Benzinga
    What's Going On With Actinium Pharmaceuticals Stock?
    Actinium Pharmaceuticals Inc (AMEX:ATNM) shares are trading higher Tuesday after the company announced full data results from the pivotal Phase 3 SIERRA trial in patients with active, relapsed or... 
    Via Benzinga
    Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket
    Gainers Troika Media Group Inc (NASDAQ: TRKA) shares rose 65.9% to $0.37 in pre-market trading after dropping 4% on Friday. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    It's time to start another day of trading with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday! 
    Via InvestorPlace
    Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
    U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session. 
    Via Benzinga
    Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
    Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on... 
    Via Benzinga
    Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel... 
    Via Benzinga
    4 Analysts Have This to Say About Actinium Pharmaceuticals
    Over the past 3 months, 4 analysts have published their opinion on Actinium Pharmaceuticals (AMEX:ATNM) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
    Via Benzinga
    Why Is Getty Images (GETY) Stock Up 33% Today?
    Getty Images (GETY) stock is rising higher on Monday with heavy trading despite a lack of news concerning the company today. 
    Via InvestorPlace
    Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
    Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product... 
    Via Benzinga
    PERF Stock Soars 21% on First Trading Day
    Perfect (PERF) stock is taking off on Monday as investors pump shares higher on their first day of trading after a SPAC merger. 
    Via InvestorPlace
    Actinium (ATNM) Stock Pops on Positive Trial Results
    Actinium Pharmaceuticals (ATNM) stock is gaining on Monday after posting positive results from a Phase 3 clinical trial. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Welcome back and get ready for another week of trading as we break down the biggest pre-market stock movers for Monday morning! 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
      
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
    Upgrades 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.